Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)

PHASE3CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

September 30, 2005

Conditions

Rhinitis, Allergic, SeasonalHay Fever

Interventions

DRUG

Ciclesonide

200µg Ciclesonide versus Placebo

DRUG

Placebo

placebo

Trial Locations (1)

Altana/Nycomed, Mississauga